Abstract:Background Myopia is increasing in prevalence and is currently recognized as a significant public health issue worldwide, particularly in China. Once myopia develops, appropriate clinical interventions need to be prescribed to slow its progression. Currently, several publications indicate that myopic defocus (MD) retards eye growth and myopia progression. However, no clinical trials have compared the outcomes of different MD spectacle lenses in the same observational group, especially in mainland China. The aim of the present study is to compare the myopia control efficiency of two different MD spectacle lenses: defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition lenses (PALs). Methods The trial is designed as a 3-year, prospective, randomized, multicenter clinical trial of schoolchildren treated with DIMS lenses and PALs. A total of 600 Chinese primary school children aged 6–12 years will be recruited, and each group is intended to include 300 subjects. The inclusion criteria are myopia between − 1.00 and − 5.00 diopters and astigmatism ≤ 1.50 diopters. The follow-up time points will be 1 month (m), 3 m, 6 m, 12 m, 18 m, 24 m, 30 m, and 36 m. The primary outcome will be determined by the difference between the two groups in cycloplegic spherical equivalent refraction between baseline and the last follow-up visit. The secondary outcome is the axial length, and the exploratory outcomes include ocular biometric measures, peripheral refraction, binocular vision, accommodation, compliance, and the results of questionnaires related to wearing experiences. Discussion The present study will be the first randomized controlled trial in myopic primary school children treated with DIMS lenses and PALs in China. The results will indicate whether and how much different MD mechanisms retard myopia progression and axial elongation. In addition, the comparison will provide information on the clinical efficacy and safety of DIMS lenses and PALs, including information related to wearing experiences and visual function. Trial registration Chinese Clinical Trial Registry (ChiCTR), ChiCTR1900025645. Registered on 3 September 2019. http://www.chictr.org.cn/showproj.aspx?proj=42927 .

Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents

Author Correction: Synergistic Effects of Defocus-Incorporated Multiple Segments and Atropine in Slowing the Progression of Myopia

Different efficacy in myopia control: Comparison between orthokeratology and defocus-incorporated multiple segment lenses

Comparison of the Effects of Orthokeratology and Highly Aspherical Lenselets in Achieving Myopia Control and Defocus in Adolescents

Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial

Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese children

Comparison of myopic control between orthokeratology contact lenses and defocus incorporated multiple segments spectacle lenses

Combination effect of optical defocus and low dose atropine in myopia control: Study protocol for a randomized clinical trial

A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine

Effect of 0.01% atropine combined with orthokeratology lens on axial elongation: a 2-year randomized, double-masked, placebo-controlled, cross-over trial

Evaluating the Myopia Progression Control Efficacy of Defocus Incorporated Multiple Segments (DIMS) Lenses and Apollo Progressive Addition Spectacle Lenses (pals) in 6- to 12-Year-old Children: Study Protocol for a Prospective, Multicenter, Randomized Controlled Trial

The Synergistic Effects of Orthokeratology and Atropine in Slowing the Progression of Myopia.

The efficacy and safety of combination therapy of repeated low-level red light and defocus-incorporated multiple segments spectacle lenses for myopia control in children: the study protocol for a 12-month, randomized, parallel-controlled, and single-center clinical trial

Therapeutic effects of orthokeratology lens combined with 0.01% atropine eye drops on juvenile myopia

Clinical effect of defocus incorporated multiple segments (DIMS) spectacles combined with low-concentration atropine in fast-progressing myopic children

Effectiveness of orthokeratology and myopia control spectacles in a real-world setting in China

Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis

Comparison of trial lens and computer-aided fitting in orthokeratology: A multi-center, randomized, examiner-masked, controlled study

Overnight orthokeratology is comparable with atropine in controlling myopia

Novel application of multispectral refraction topography in the observation of myopic control effect by orthokeratology lens in adolescents

Comparison of Two Main Orthokeratology Lens Designs in Efficacy and Safety for Myopia Control